Sales Dip While Adjusted Earnings Hold
Back in the trenches again with Leggett & Platt (NYSE: LEG), reporting a second-quarter sales slump of six percent compared to last year. That stings, especially when you're juggling divestitures and shaky market demand. But hey, there's a silver lining in there. The adjusted EPS climbed to $0.39, which is up nine cents from last year, thanks to some cost tightening and unexpected but apparently one-off favorable items. So, not all doom and gloom, just mostly. They're hanging on by their trade rod and wire business—which, given their soft mattress market, is holding the fort.
The Bedding Industry's Rough Patch
It ain't looking pretty for the bedding sector; slumping mattress market units in the U.S. are down in low double digits. Retailer shifts and shaky consumer activity aren't doing any favors. Throw in some consolidations and bankruptcies, and you start to see why Leggett's taking hits. But then there's a glimpse of resolve—strong performances in trade rod and wire sales, bolstering that segment amidst the volume hits.
What About Other Segments?
On the Specialized Products front, the tale isn't much different. Trade sales took a nosedive, plummeting 19%. The Aerospace divestiture pulled the rug, chopping off 16% from sales with what's left suffering a four percent drop from a sluggish market, mainly in Asia. It seems Europe and North America aren't feeling as much pain, but the general market vibe? Not great.
- Furniture, Flooring & Textiles saw a tiny trade sales uplift. One percent's not exactly fireworks, but given the climate, it's something.
- Growth in textiles couldn't fully shelter the declines in home and work furniture sales.
- The silver lining? Some gains from cost recovery in tariffs.
“Our [Leggett & Platt's] teams held strong amidst weakness,” says CEO Karl Glassman. But there’s only so much cushioning before the bumps get too much.
Eyes on the Somnigroup Merger
Now, the big twist in Leggett's story is the planned merger with Somnigroup International Inc. (NYSE: SGI). It's not set in stone yet but all eyes are on August 20th for shareholder approval. Regulatory approvals are part of the balancing act, but the end goal? A streamline with a valued customer, potentially unlocking strategic and financial gains. However, caution abounds. Some risks hang over their heads; a no-go could punt shares and projections off a cliff.
Debt, Dividends, and Cash Flow
To stay afloat, Leggett's digging in with a net debt of 2.6 times their trailing 12-month adjusted EBITDA. Total debt lives at $1.5 billion as of June’s end. Dividends remain constant at $0.05 per share, paid out of a $46 million operating cash flow—down $38 million year-over-year. Not the most reassuring picture but they've got some breathing room in working capital investments.
Looking Ahead
Challenges sit on the horizon with continued macroeconomic headwinds set to curb consumer demand. The mood music won't improve overnight. Leggett & Platt seems heads down, focused on strategic targets while skirting hurdles. The battle's far from over, but the Somnigroup deal may offer a rare lifeline, assuming everything falls into place after August 20th.
This landscape's messier than a broker’s desk post-crash, but there’s value in watching where the chips fall. LEG's suppliers, shareholders, and any spare traders ought to buckle up—it could be a wild one.
